US Stock MarketDetailed Quotes

INGN Inogen

Watchlist
  • 7.280
  • +0.010+0.14%
Close Apr 29 16:00 ET
195.74MMarket Cap-4.79P/E (TTM)
Pre-Market
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Jan 27 08:31
    NEWS 1/26
    $Inogen (INGN.US)$
    Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
    Sunday, 26th January at 12:00 pm
    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has entered into a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ, "Yuwell"), a global home healthcare medical device manufacturer...
    Jaguar8
    Jaguar8
    Dec 31, 2024 08:43
    NEWS TODAY
    $Inogen (INGN.US)$
    Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
    Monday, 30th December at 8:30 am
    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company's ability to market and meet the various needs of patients with chronic...
    Trytosaveabit
    Trytosaveabit
    Aug 7, 2024 04:41
    Hmm
    $Inogen (INGN.US)$
    Second Quarter 2024 Financial Results
    Second quarter total revenue increased 6.1% to $88.8 million from $83.6 million in the second quarter of 2023, primarily driven by higher demand and new customers in international and domestic business-to business sales, partially offset by lower direct-to-consumer sales and rental revenue.
    Total gross margin was 48.1% in the second quarter of 2024 versus 40.7% in the comparative period in 2023. The increase was driven primarily by low...
    Moomoo AI
    Moomoo AI
    Feb 9, 2024 19:21
    Investors' belief that strong revenue growth is not on the horizon for Inogen contributes to its low P/S ratio. The company's underwhelming revenue outlook is a major factor. A change of fortune is needed to justify a higher P/S in the future.
    Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%
Read more

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀